SANXING(SH:601567) Xin Lang Cai Jing·2025-10-16 01:25Group 1 - On October 15, Samsung Medical's stock rose by 2.07%, with a trading volume of 555 million yuan [1] - The financing data shows that on the same day, Samsung Medical had a financing purchase amount of 54.05 million yuan and a net financing purchase of 9.43 million yuan [1] - As of October 15, the total balance of margin trading for Samsung Medical was 375 million yuan, with a financing balance of 372 million yuan, accounting for 1.01% of the circulating market value [1] Group 2 - As of June 30, the number of shareholders of Samsung Medical increased to 29,000, a rise of 76.91%, while the average circulating shares per person decreased by 43.15% to 48,732 shares [2] - For the first half of 2025, Samsung Medical achieved an operating income of 7.972 billion yuan, a year-on-year increase of 13.93%, and a net profit attributable to the parent company of 1.230 billion yuan, up 6.93% year-on-year [2] Group 3 - Samsung Medical has distributed a total of 6.407 billion yuan in dividends since its A-share listing, with 3.329 billion yuan distributed in the last three years [3] - As of June 30, 2025, Hong Kong Central Clearing Limited was the fourth largest circulating shareholder of Samsung Medical, holding 47.9803 million shares, an increase of 3.9134 million shares compared to the previous period [3]